found this not to be the case in subjects undergoing repeat methionine loading, but have not addressed this explicitly in our study.
In summary, our data show that levels of both total and non-protein-bound homocyst(e)ine are approximately 25% lower at the time hepatic proteins display an acute phase response. If fasting homocyst (e)ine is being measured in the assessment of a patient with coronary artery disease, testing is best deferred for r7 days after AMI.
ntracoronary ultrasound (ICUS ) -guided stent deployment achieves a significantly larger postprocedural lumen and allows a safe withdrawal of systemic anticoagulation after the procedure with a low incidence of subacute thrombosis, recurrence of clinical symptoms, and restenosis.' However, the review and quantitative analysis from videotape of a conventional ICUS examination (2-dimensional [2-D] ) is cumbersome, time-consuming, and requires expert image interpretation, with risk of considerable interobserver disagreement, especially during coronary intervention.* In this study, the ICUS measurements obtained after angiographic optimization of stent deployment with a conventional, manual tracing of the lumen are compared with on-line automatic measurements obtained with a new system of 3-dimensional (3-D) ICUS reconstruction.
. . . Forty-nine stents in 33 patients (24 men and 9 women, mean age 60 + 9 years) were examined in this study. Self-expanding (19x Wallstent) and balloon-expandable (19x Palmaz-Schatz, 6x Micro-Stent, 3x Cordis, lx Multi-Link, lx Gianturco-Roubin) stems were implanted in 14 left anterior descending artery lesions (n = 17)) 1 left circumflex artery lesion (n = 2), 12 right coronary artery lesions (n = 23), and 6 saphenous venous graft lesions (n = 7). Coronary stenting was performed either as an elective (n = 26) or as a bailout procedure (n = 23) in restenotic (n = 17) and in de novo (n = 32) lesions. All patients received acetylsalicylic acid 250 mg and heparin 10,000 IU after insertion of the arterial sheath. If necessary, administration of heparin was repeated in order to maintain an activated clotting time of >300 seconds.
Quantitative coronary angiography was performed by means of a previously described computer-assisted automatic quantitative analysis system (CAAS II, Pie Medical Data, Maastricht, or ACA, Philips DCI, Eindhoven, The Netherlands,) using an edge-detection algorithm. 3 Before stent placement, predilatation with standard balloon angioplasty was performed. For the balloon-expandable stents, a diameter of the delivery balloon matching the angiographic reference lumen diameter was selected. Then all the stents were redilated with a balloon 20.25 mm larger than the angiographic reference lumen diameter. Dilatations within the stent were performed at >14 atm with short balloons of low compliance (Chubby or Speedino, Schneider Europe, Zurich, Switzerland). The procedural end point was considered the achievement of a uniform lumen of the treated segment, with an intrastent minimal luminal diameter equal to or greater than the user-defined reference diameter. After intracoronary administration of 1 to 3 mg of isosorbide dinitrate, the ICUS examination was performed using a 2.9Fr monorail system with a 30 MHz ultrasound transducer (MicroView, CVIS, Sunnyvale, California).
Ultrasound images were recorded continuously on videotape during withdrawal of the ultrasound probe along the stented segment with the use of a motorized pullback device at a constant speed of 1 .O mm/s. Based on the recorded images, the proximal and distal reference segments were chosen within 5 mm from the stent endings. The ICUS cross section with the minimal intrastent luminal area was then identified, and the manually traced contour of this lumen area was visibly maintained while scrolling Table I . Intrastent measurements provided by 2-D ICUS were higher than those by 3-D; however, the difference was significant only for the maximal lumen diameter. The best correlation between these 2 methods was found for minimal intrastent cross-sectional area ( Figure 1) ; for Wallstents, however, this correlation was weaker than for other stents (r = 0.63 vs r = 0.89). Both ultrasound methods revealed that the intrastent minimal luminal cross-sectional area was localized at 1 of the endings (within the first or last 2 mm) in 3 1 of 49 analyzed stents (63%). There was no significant difference between 2-D and 3-D measurements in cross-sectional lumen area for proximal and distal references (r = 0.89 and r = 0.86, respectively ) . However, the presence of atherosclerotic encroachment of >50% in reference segments was found in 20 stents (40.8%) by 2-D and in 11 stents (22.4%) by 3-D ICUS. ployment were derived from the experience of the Milan group' with slight modification. They consisted of: ( 1) complete apposition of the stent to the vessel wall without protrusion of the struts within the lumen; (2) minimal to maximal intrastent diameter ratio (symmetry index) >0.7; and (3) minimal stent lumen area ~80% of the average lumen area of the proximal and distal reference segments, or equal to or more than the distal or proximal reference lumen area. Two-dimensional ultrasound showed that the quantitative criteria of adequate stent deployment were met in 19 stents (38.8%), whereas 3-D ultrasound revealed that these criteria were reached in only 15 of 49 stents (30.6%) (Figure 2 ). In 5 of 15 cases (33.3%) assessed by 3-D as properly deployed, 2-D ICUS evaluation was different. Both ultrasound methods detected 4 patients (8.2%) with protrusion of stent struts within the vessel lumen. In these patients, the symmetry index <0.7 was found as additional evidence of stent underexpansion ( Figure 3 ) .
Matched measurements provided by both methods were compared by using a 2-tailed Student's t test for paired data and linear regression analysis. Mean 2 SD difference of the signed difference was calculated as proposed by Bland and Altnian5 A p value <0.05 was considered statistically significant.
After the stenting procedure, the minimal lumen diameter and corresponding minimal luminal crossUsing the information provided by on-line ultrasound measurements, we performed an additional intrastent dilatation in 7 patients (2 1.2% ) , including all patients with a symmetry index <0.7. Nevertheless, in 1 of these patients in whom the GianturcoRoubin stent was implanted as a bailout procedure (because of severe dissection after balloon angioplasty), a subacute stent thrombosis occurred. The patient underwent successful surgery without developing myocardial infarction.
762 THE AMERICAN JOURNAL OF CARDIOLOGY" VOL. 77 APRIL 1, 1996 tive angiography were 2.99* t 0.5 1 mm and 7.23 + 2.38 mm2, respectively. Percent diameter stenosis assessed on-line was -16 + 11.4%. Negative percent diameter stenosis was reached in 45 stents (92%).
Of the 49 stents reconstructed, 6 ( 12.2%) needed major manual correction due to a failure of the algorithm used for lumen detection induced by the presence of side branches and shadowing from calcium.
The time required for frame selection and measurement was 4.4 5 1.5 minutes for the conventional 2- . . .
ICUS is a new imaging technique, providing valuable information concerning vessel wall and plaque composition. Based on the results of extensive tests performed in various clinical settings, it appears that ICUS correlates well with histology6 and provides accurate and reproducible measurements of lumen and plaque.' Furthermore, it has been proven that this technique is relatively safe7 and helpful in the decision-making process.* A report from the group in Milan ' clearly showed the inaccuracies of angiographic assessment after stent deployment and the importance of ICUS in the optimization of stent deployment. However, assessment of the adequacy of stent deployment based on analysis of the cross-sectional images acquired during manual withdrawal of the ultrasound catheter is a potential source of error because detection of the narrowest site within the stented segment is subjective and may be inaccurate. To circumvent this limitation, we performed ultrasound examinations using a motorized pullback device at constant speed. This was a prerequisite for the on-line application of 3-D ICUS of an analyzed segment. This approach has the potential to assess lumen dimensions and geometry precisely within the stent, and to evaluate the dimensions and vessel wall characteristics of the reference segments.' Furthermore, this method makes the ultrasound measurements more objective, decreases their variability, and may facilitate further interventions.
The fact that 33.3% of the cases selected by 3-D analysis as properly deployed were missed by 2-D ICUS suggests that during on-line 2-D analysis, the narrowest site within the stent can be missed in a significant number of cases. Comparison of the measurements provided by these 2 methods has shown that systematic overestimation of intrastent dimensions by 2-D ICUS occurs, resulting in a higher percentage of adequately deployed stents than found by 3-D ICUS. The probability of disagreement between both ICUS modes in detecting the narrowest intrastent site increases with the length of the stented segment. The lower correlation between 2-D and 3-D ICUS measurements of minimal intrastent luminal area for Wallstents (which are more symmetric but longer than other stents) supports this thesis. Ultrasound analysis of the reference segments has shown that less diseased segments (but rather with larger lumen areas) were selected by 3-D ICUS. This fact is reflected by a larger number of patients with significant plaque burden within the reference segments found by 2-D, which further explains the tendency to overestimate the results of stent deployment by 2-D ICUS. Our data also revealed interesting findings concerning the localization of the minimal intrastent luminal area. The fact that in most patients this parameter was identified at 1 of the stent endings reflects the current approach to stent deployment. According to common practice, a short balloon of low compliance is mainly chosen for additional intrastent dilatation to avoid an injury of the nonstented segments.' As a consequence, a smaller expansion of the stent extremities occurs (Figure 4) . This results in a fusiform shape of the stent, which is visible on the longitudinal 3-D display.
In conclusion, on-line 3-D ICUS is feasible during stent implantation, more sensitive than 2-D ICUS h the assessment of optimal stent expansion, and requires a shorter time for analysis.
